Giacomo Deferrari

Giacomo Deferrari

Auto-generated profile, based on publicly available information

Giacomo Deferrari

Department of Cardionephrology, University of Genoa, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
MPMarc A. Pohl
Marc A. Pohl
SBSamuel Blumenthal
Samuel Blumenthal
DCDaniel J. Cordonnier
Daniel J. Cordonnier
FAFernando De Alvaro
Fernando De Alvaro
GDGiacomo DeFerrari
Giacomo DeFerrari
ELEdmund J. Lewis
Edmund J. Lewis
Elevated arterial pressure is a major risk factor for progression to ESRD in diabetic nephropathy. However, the component of arterial pressure and level of BP control for optimal renal outcomes are disputed. Data from 1590 hypertensive patients with type 2 diabetes in the Irbesartan Diabetic Nephropathy Trial (IDNT), a randomized, double-blind, placebo-controlled trial performed in 209 clinics worldwide, were examined, and the effects of baseline and mean follow-up systolic BP (SBP) and diastolic BP and the interaction of assigned study medications (irbesartan, amlodipine, and placebo) on progressive renal failure and all-cause mortality were assessed. Other antihypertensive agents were added to achieve predetermined BP goals. Entry criteria included elevated baseline serum creatinine concentration up to 266 μmol/L (3.0 mg/dl) and urine protein excretion >900 mg/d. Baseline BP averaged 159/87 ± 20/11 mmHg. Median patient follow-up was 2.6 yr. Follow-up achieved SBP most strongly predicted renal outcomes. SBP >149 mmHg was associated with a 2.2-fold increase in the risk for doubling serum creatinine or ESRD compared with SBP <134 mmHg. Progressive lowering of SBP to 120 mmHg was associated with improved renal and patient survival, an effect independent of baseline renal function. Below this threshold, all-cause mortality increased. An additional renoprotective effect of irbesartan, independent of achieved SBP, was observed down to 120 mmHg. There was no correlation between diastolic BP and renal outcomes. We recommend a SBP target between 120 and 130 mmHg, in conjunction with blockade of the renin-angiotensin system, in patients with type 2 diabetic nephropathy.

1 April 2003 in Diabetes
Verified
Journal Article
Closed access
PDF file
SDSophie Doublier
Sophie Doublier
GSGennaro Salvidio
Gennaro Salvidio
ELEnrico Lupia
Enrico Lupia
VRVesa Ruotsalainen
Vesa Ruotsalainen
DVDaniela Verzola
Daniela Verzola
GCGiovanni Camussi
Giovanni Camussi
We studied the distribution of nephrin in renal biopsies from 17 patients with diabetes and nephrotic syndrome (7 type 1 and 10 type 2 diabetes), 6 patients with diabetes and microalbuminuria (1 type 1 and 5 type 2 diabetes), and 10 normal subjects. Nephrin expression was semiquantitatively evaluated by measuring immunofluorescence intensity by digital image analysis. We found an extensive reduction of nephrin staining in both type 1 (67 ± 9%; P < 0.001) and type 2 (65 ± 10%; P < 0.001) diabetic patients with diabetes and nephrotic syndrome when compared with control subjects. The pattern of staining shifted from punctate/linear distribution to granular. In patients with microalbuminuria, the staining pattern of nephrin also showed granular distribution and reduction intensity of 69% in the patient with type 1 diabetes and of 62 ± 4% (P < 0.001) in the patients with type 2 diabetes. In vitro studies on human cultured podocytes demonstrated that glycated albumin and angiotensin II reduced nephrin expression. Glycated albumin inhibited nephrin synthesis through the engagement of receptor for advanced glycation end products, whereas angiotensin II acted on cytoskeleton redistribution, inducing the shedding of nephrin. This study indicates that the alteration in nephrin expression is an early event in proteinuric patients with diabetes and suggests that glycated albumin and angiotensin II contribute to nephrin downregulation.

1 February 2005 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
RARobert C. Atkins
Robert C. Atkins
EBEsther M. Briganti
Esther M. Briganti
JLJulia B. Lewis
Julia B. Lewis
LHLawrence G. Hunsicker
Lawrence G. Hunsicker
GBGregory Braden
Gregory Braden
ELEdmund J. Lewis
Edmund J. Lewis

1 November 2008 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
DVDaniela Verzola
Daniela Verzola
MGMaria Teresa Gandolfo
Maria Teresa Gandolfo
GGGianfranco Gaetani
Gianfranco Gaetani
AFAnnamaria Ferraris
Annamaria Ferraris
RMRosa Mangerini
Rosa Mangerini
GGGiacomo Garibotto
Giacomo Garibotto
We examined the hypothesis that senescence represents a proximate mechanism by which the kidney is damaged in type 2 diabetic nephropathy (DN). As a first step, we studied whether the senescence-associated β-galactosidase (SA-β-Gal) and the cell cycle inhibitor p16INK4Aare induced in renal biopsies from patients with type 2 DN. SA-β-Gal staining was approximately threefold higher ( P < 0.05) than in controls in the tubular compartment of diabetic kidneys and correlated directly with body mass index and blood glucose. P16INK4Aexpression was significantly increased in tubules ( P < 0.005) and in podocytes ( P = 0.04). Nuclear p16INK4Ain glomeruli was associated with proteinuria ( P < 0.002), while tubular p16INK4Awas directly associated with body mass index, LDL cholesterol, and HbA1c ( P < 0.001–0.05). In a parallel set of experiments, proximal tubule cells passaged under high glucose presented a limited life span and an approximately twofold increase in SA-β-Gal and p16INK4Aprotein. Mean telomere lengths decreased ∼20% as an effect of replicative senescence. In addition, mean telomere decreased further by ∼30% in cells cultivated under high glucose. Our results show that the kidney with type 2 diabetic nephropathy displays an accelerated senescent phenotype in defined renal cell types, mainly tubule cells and, to a lesser extent, podocytes. A similar senescent pattern was observed when proximal tubule cell cultures where incubated under high-glucose media. These changes are associated with shortening tubular telomere length in vitro. These findings indicate that diabetes may boost common pathways involving kidney cell senescence, thus reinforcing the role of the metabolic syndrome on biological aging of tissues.

1 November 2007 in Kidney International
Verified
Journal Article
Closed access
DVD. Verzola
D. Verzola
MGM.T. Gandolfo
M.T. Gandolfo
FFF. Ferrario
F. Ferrario
MRM.P. Rastaldi
M.P. Rastaldi
BVB. Villaggio
B. Villaggio
GGGiacomo Garibotto
Giacomo Garibotto

1 February 1999 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
RPR Pontremoli
R Pontremoli
FVF Viazzi
F Viazzi
CMC Martinoli
C Martinoli
MRM Ravera
M Ravera
CNC Nicolella
C Nicolella
GDG Deferrari
G Deferrari
Increased renal resistance detected by ultrasound (US) Doppler has been reported in severe essential hypertension (EH) and recently was shown to correlate with the degree of renal impairment in hypertensive patients with chronic renal failure. However, the pathophysiological significance of this finding is still controversial. In a group of 211 untreated patients with EH, we evaluated renal resistive index (RI) by US Doppler of interlobar arteries and early signs of target organ damage (TOD). Albuminuria was measured as the albumin to creatinine ratio (ACR) in three non-consecutive first morning urine samples. Left ventricular mass was evaluated by M-B mode echocardiography, and carotid wall thickness (IMT) by high resolution US scan. RI was positively correlated with age (r=0.25, P=0.003) and systolic blood pressure (SBP) (r=0.2, P=0.02) and with signs of early TOD, namely ACR (r=0.22, P=0.01) and IMT (r=0.17, P<0.05), and inversely correlated with renal volume (r=-0.22, P=0.01) and diastolic blood pressure (r=-0.23, P=0.006). Multiple linear regression analysis demonstrated that age, gender, ACR and SBP independently influence RI and together account for approximately 20% of its variations (F=8.153, P<0.0001). When clinical data were analysed according to the degree of RI, the patients in the top quartile were found to be older (P<0.05) and with higher SBP (P<0.05) as well as early signs of TOD, namely increased ACR (P<0.002) and IMT (P<0.005 by ANOVA), despite similar body mass index, uric acid, fasting blood glucose, lipid profile and duration of hypertension. Furthermore, patients with higher RI showed a significantly higher prevalence of microalbuminuria (13 vs 12 vs 3 vs 33% chi2=11.72, P=0.008) and left ventricular hypertrophy (40 vs 43 vs 32 vs 60%, chi2=9.25, P<0.05). Increased RI is associated with early signs of TOD in EH and could be a marker of intrarenal atherosclerosis.